Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer propertiesLY-JK-374892
产品编号:
LY-JK-374892纯度:98%CAS:50-35-1
英文名称:Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties
Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties